ATLAS fair value
ATLAS has no fair value for this stock today.
Lifeward stock price today, ATLAS forecast and fair value
Healthcare · Medical Devices · NASDAQ
Prices as of Oct 27, 2026 · USD
ATLAS has no fair value for this stock today.
48%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS's model gives Lifeward a 48% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between $5.43 and $6.67; in 9 out of 10, between $4.52 and $8.01. Estimated annual volatility is 56%.
ATLAS does not publish a fair value for LFWD right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks LFWD has traded between $4.14 and $9.61. Today it is 36.8% below that high and 47% above its low.
On the business: revenue fell 14.1% year over year; net margin is 90.4%.
Its beta is 0.40: it tends to move less than the market.
Lifeward Ltd. is a medical device company that develops and commercializes rehabilitation technologies designed to improve mobility and support recovery for people with physical and neurological conditions.
Want to see everything about Lifeward?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
Lifeward Ltd. is a medical device company that develops and commercializes rehabilitation technologies designed to improve mobility and support recovery for people with physical and neurological conditions.
48%: close to a coin flip. In half of the simulated outcomes, LFWD ends the month between $5.43 and $6.67.
Lifeward's market capitalization is $16.6M. We do not show a P/E because it has no positive earnings to base one on.
ATLAS estimates annual volatility at 56%. In a typical month, half of the outcomes end between $5.43 and $6.67.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy